Pharmaceutical Supply Procurement for Indian Army Healthcare Services

Work Description - NA

This tender, with Bid Number GEM/2026/B/7844439, is being issued by the Department of Military Affairs, under the Ministry of Defence, for the procurement of a comprehensive range of pharmaceutical supplies on behalf of the Indian Army. The bid is open for submission from 07-08-2026 at 2:32 PM until 17-08-2026 at 3:00 PM. The procurement encompasses a significant total quantity of 287,905 units across a diverse list of critical medications, including injectables such as Plazomicin 500mg, Vasopressin, Vecuronium Bromide, Cisatracurium Besylate, Dexmedetomidine, Amikacin, Diltiazem, Etomidate, Glycopyrrolate, Midazolam, Diazepam, Haloperidol, S-Amlodipine, Metoprolol, Inj Bupivacaine HCl, Adenosine, Ceftazidime, Diclofenac, Ampicillin, Ranitidine HCl, and Pheniramine Maleate, as well as oral formulations including Acyclovir, Ondansetron (4mg and 8mg), Dexamethasone, Baclofen, Aceclofenac, Acetazolamide, Clobazam, Dicyclomine plus Paracetamol, Diethylcarbamazine, Hydroxyurea, Ranitidine, Entacavir, Tenofovir plus Lamivudine plus Dolutegravir (TLD), and Tinidazole. This broad spectrum of medications signifies a substantial requirement for vital pharmaceutical products essential for the healthcare services of the Indian Army.